Control 7 is a next-generation probiotic developed through a three-way collaboration between Cornell University (USA) and ABH — translating LBPs-grade (live biotherapeutics) research into a consumer-ready product.
Key Highlights
- Built on drug-grade probiotic research methodology
- Backed by our LeffCul® viability testing and LeffMic® preservation platforms
- Supported by a global commercial probiotic activity database
Available Formats
Powders, granules, stick packs and hard capsules — manufactured in our ≤26% humidity probiotics workshop with full MES traceability.